Home › Acute Lymphoblastic Leukemia › Washington › Spokane
Acute Lymphoblastic Leukemia clinical trials in Spokane, WA
3 studies for Acute Lymphoblastic Leukemia are looking for participants at sites in and around Spokane (within about 30 miles). Open a study to see who can join and how to contact the study team.
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Cancer Care Northwest - Spokane South, Spokane
- Cancer Care Northwest-Valley, Spokane
- Cancer Care Northwest-North Spokane, Spokane
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RecruitingObservational study
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Acute Lymphoblastic Leukemia trials in other cities
- Houston, TX28 studies
- New York City, NY24 studies
- Seattle, WA21 studies
- Baldwin Park, CA21 studies
- Chicago, IL19 studies
- Atlanta, GA18 studies
- Memphis, TN16 studies
- Philadelphia, PA16 studies
- Washington, DC16 studies
- Boston, MA15 studies
- Los Angeles, CA14 studies
- Durham, NC13 studies
Other studies in Spokane
- Non-Small Cell Lung Cancer13 studies
- Colorectal Cancer9 studies
- Breast Cancer8 studies
- Ovarian Cancer8 studies
- Parkinson's Disease7 studies
- Head and Neck Squamous Cell Carcinoma7 studies
- Chronic Lymphocytic Leukemia6 studies
- Cancer (all types)6 studies
- Prostate Cancer6 studies
- Macular Degeneration5 studies
- Geographic Atrophy5 studies
- Melanoma5 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.